• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
CCAIM

CCAIM

Novel AI to transform healthcare

  • Home
  • About
    • Our Aims
    • Leadership
    • Joint Steering Committee
    • Independent Scientific Advisory Board
    • Our students
    • Visitors
    • Vacancies
  • Research
    • Papers
    • Breakthroughs
    • Demonstrators
    • Research Update: COVID-19
    • Blog
  • News
    • Latest News
    • COVID-19 News
  • Events
    • Seminar Series
    • WeCREATE
    • Inaugural Event
    • AI Clinic
  • Summer School
    • Program
    • Topics
    • Speakers
    • Industry
    • Participate
    • Summer School in Numbers
    • Exhibition
    • FAQ
  • Get involved
    • Collaborate
    • PhD Programmes
    • Partners
  • Connect

Disease Progression in Prostate Cancer Patients – How we approach the problem with Machine Learning

16 August 2022 by Andreas Bedorf

This post refers to a newly published paper involving members of the van der Schaar Lab inside CCAIM. Find out more here.

Illustration of data flow and model overview
(Top) Illustration of data collection and its use in prediction in our set-up.  (Bottom) A schematic illustrating the risk prediction and temporal clustering aspects of the model.  The green and yellow lines represent longitudinal data.  Cluster 4 in this illustration contains higher risk patients than cluster 3, hence an “earlier” time-to-event profile is shown.

In their paper, Changhee Lee, Alexander Light, Evgeny Saveliev, Mihaela van der Schaar, and Vincent Gnanapragasam present the first machine learning application for a dynamic risk prediction and temporal clustering of continuous data. This offers the opportunity to inform personalised follow-ups in prostate cancer active surveillance patients. Their algorithm, surpassing the current standards significantly, has the potential to be developed into a useable clinical tool.

Evgeny Saveliev, PhD Student at the van der Schaar Lab has created a short comprehensive video to explain the approach in a nutshell:

To learn more about the model, using cutting-edge machine learning (deep learning) to cut out assumptions and constraints of traditional statistical methods, you can discover an extensive explanative post on the van der Schaar Lab website here:

https://www.vanderschaar-lab.com/machine-learning-tackles-the-problem-of-dynamic-disease-progression-in-prostate-cancer-patients/

To illustrate the potential utility of their work, the authors provide an interactive web app, demonstrating a possible future clinical platform, which we encourage the reader to try out. More information about this can be found following the link above.

The paper is accessible here:

Developing machine learning algorithms for dynamic estimation of progression during active surveillance for prostate cancer

Changhee Lee, Alexander Light, Evgeny Saveliev, Mihaela van der Schaar, Vincent Gnanapragasam

SURVIVAL ANALYSIS
CLUSTERING AND PHENOTYPING
PERSONALISED MEDICINE
DEEP LEARNING
Abstract

Active Surveillance (AS) for prostate cancer is a management option that continually monitors early disease and considers intervention if progression occurs. A robust method to incorporate “live” updates of progression risk during follow-up has hitherto been lacking.

To address this, we developed a deep learning-based individualized longitudinal survival model using Dynamic-DeepHit-Lite (DDHL) that learns data-driven distribution of time-to-event outcomes. Further refining outputs, we used a reinforcement learning approach (Actor-Critic) for temporal predictive clustering (AC-TPC) to discover groups with similar time-to-event outcomes to support clinical utility.

We applied these methods to data from 585 men on AS with longitudinal and comprehensive follow-up (median 4.4 years). Time-dependent C-indices and Brier scores were calculated and compared to Cox regression and landmarking methods. Both Cox and DDHL models including only baseline variables showed comparable C-indices but the DDHL model performance improved with additional follow-up data. With 3 years of data collection and 3 years follow-up the DDHL model had a C-index of 0.79 (± 0.11) compared to 0.70 (± 0.15) for landmarking Cox and 0.67 (± 0.09) for baseline Cox only. Model calibration was good across all models tested. The AC-TPC method further discovered 4 distinct outcome-related temporal clusters with distinct progression trajectories. Those in the lowest risk cluster had negligible progression risk while those in the highest cluster had a 50% risk of progression by 5 years.

In summary we report a novel machine learning approach to inform personalised follow-up during active surveillance which improves predictive power with increasing data input over time.

Category: News, Research, VideoTag: CCAIM, deep learning, demonstrator, disease, healthcare, Nature, paper, personalised medicine, prediction, time-series-analysis, van der Schaar
Previous Post: « CCAIM at ICML 2022
Next Post: exhib »

Navigation

Home

News

About

University of Cambridge

  • University A-Z
  • Contact the University
  • Accessibility
  • Data Protection
  • Terms and conditions

Newsletter

Sign-up for updates on our research.

Follow us

  • Twitter
  • LinkedIn
  • YouTube

Copyright © 2023 CCAIM

Return to top

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

CCAIM
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!